Watch live: Reimagining Clinical Trials – Expanding Access by Meeting Patients Where They Are
Yet, they are too often positioned as a last resort rather than a viable care option, limiting patient access, slowing enrollment and making the path to new treatment options longer. Identifying and matching patients to the right clinical trial opportunity remains the single-largest cause of clinical trial delays, with many trials failing to meet their initial enrollment targets. But meeting an enrollment target doesn’t guarantee the right patients are represented, as trials consistently fall short of reflecting the communities that carry the greatest burden of disease.
- ▪Yet, they are too often positioned as a last resort rather than a viable care option, limiting patient access, slowing enrollment and making the path to new treatment options longer.
- ▪Identifying and matching patients to the right clinical trial opportunity remains the single-largest cause of clinical trial delays, with many trials failing to meet their initial enrollment targets.
- ▪But meeting an enrollment target doesn’t guarantee the right patients are represented, as trials consistently fall short of reflecting the communities that carry the greatest burden of disease.
Opening excerpt (first ~120 words) tap to expand
News Watch live: Reimagining Clinical Trials – Expanding Access by Meeting Patients Where They Are Comments: by TheHill.com - 05/20/26 12:00 PM ET Comments: Link copied by TheHill.com - 05/20/26 12:00 PM ET Comments: Link copied NOW PLAYING Clinical trials are one of healthcare’s most powerful tools, and one of its most underutilized pathways to patient care and innovative therapies. Yet, they are too often positioned as a last resort rather than a viable care option, limiting patient access, slowing enrollment and making the path to new treatment options longer. Identifying and matching patients to the right clinical trial opportunity remains the single-largest cause of clinical trial delays, with many trials failing to meet their initial enrollment targets.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Hill.
Discussion
0 commentsMore from The Hill
